Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Effects of miocamycin and erythromycin on polymorphonuclear cell function.

P Bacci1, A Grossi, A M Vannucchi

  • 1Division of Hematology, University of Florence, Italy.

Journal of Chemotherapy (Florence, Italy)
|October 1, 1992
PubMed
Summary

Erythromycin and miocamycin impact phagocytic cell function differently. Miocamycin significantly enhances polymorphonuclear cell (PMN) activities like chemotaxis and Candida albicans killing, unlike erythromycin.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Collection optics of JT-60SA edge Thomson scattering diagnostic.

The Review of scientific instruments·2024
Same author

Thyroiditis and COVID-19: focus on pediatric age. A narrative review.

Journal of endocrinological investigation·2024
Same author

Transition from pediatric to adult care in patients with Turner syndrome in Italy: a consensus statement by the TRAMITI project.

Journal of endocrinological investigation·2024
Same author

Late-onset and long-lasting neutropenias in the young: A new entity anticipating immune-dysregulation disorders.

American journal of hematology·2024
Same author

Whole genome sequencing in ROHHAD trios proved inconclusive: what's beyond?

Frontiers in genetics·2023
Same author

High incidence of intracranial haemorrhage in Egyptian children with congenital afibrinogenaemia.

Haemophilia : the official journal of the World Federation of Hemophilia·2022

Area of Science:

  • Immunology
  • Pharmacology
  • Microbiology

Background:

  • Erythromycin, a macrolide antibiotic, is known to enter phagocytic cells and enhance their function.
  • Polymorphonuclear cells (PMNs) are crucial immune cells involved in pathogen clearance.

Purpose of the Study:

  • To compare the in vitro effects of erythromycin and miocamycin on polymorphonuclear cell (PMN) functions.
  • To evaluate the influence of these macrolide antibiotics on key PMN activities.

Main Methods:

  • In vitro testing of PMN functions including chemotaxis, Candida albicans killing, and respiratory burst.
  • Incubation of PMNs with varying concentrations of erythromycin and miocamycin.
  • Measurement of leukotriene B4 production.

Related Experiment Videos

Main Results:

  • Erythromycin increased leukotriene B4 production in PMNs but did not affect chemotaxis, Candida albicans killing, or respiratory burst at tested doses.
  • Miocamycin significantly enhanced all tested PMN activities: chemotaxis, Candida albicans killing, and respiratory burst.
  • The observed enhancement by miocamycin was concentration-dependent.

Conclusions:

  • Miocamycin demonstrates a broader stimulatory effect on PMN functions compared to erythromycin.
  • Miocamycin may represent a more potent immunomodulatory agent for enhancing innate immune responses.
  • Further research is warranted to explore the clinical implications of miocamycin's effects on PMN function.